ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, H.
Annals of Clinical and Laboratory Science, Vol 24, Issue 5, 431-435
Copyright © 1994 by Association of Clinical Scientists


Articles

On the clinical significance of the S-phase fractions of tumors

HA Johnson

The S-phase fraction of a tumor cell population is often viewed as a general indicator of the clinical aggressiveness of that tumor. Actually, the S-phase fraction of a cancer should be interpreted as no more than an indicator of the mean duration of its mitotic cycle. The S-phase fraction of a solid tumor is difficult to measure accurately, but in principle it is a powerful predictor of the duration of the recurrence-free interval. However, since the duration of the mitotic cycle does not correlate with malignancy, the S-phase fraction cannot be used to diagnose malignancy. It is of little value in making therapeutic decisions because the duration of the mitotic cycle is not a predictor of invasion and metastasis.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Association of Clinical Scientists.